Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
d decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
d decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
2021
CDK5 knockdown increases TP53 and p27<sup>Kip1</sup> protein half-lives, increases nuclear localization of the two proteins, decreases p27<sup>Kip1</sup> p-T187 phosphorylation and induces p21<sup>Cip1</sup> in a TP53-dependent manner.
Published 2015“…<p>(<b>A</b>) Transfection with CDK5 siRNA increased the half-life of p53 and p27<sup>Kip1</sup> protein. …”
-
2022
-
2023
Structure of YOLOv5s-SBC.
Published 2024“…Compared to the original model, P-YOLOv5s-GRNF decreased parameters by 18%, decreased model size to 11.9MB, decreased FLOPs to 14.5G, and increased FPS by 4.3. …”
-
2024
-
2025
<i>cd9b</i> MO caused a decrease in neuromasts deposited at 52 hpf.
Published 2021“…B-G: Representative images of WISH of <i>claudin b</i> at 52 hpf of (b) uninjected embryos, (c) embryos with 0.5 μM Mismatch, (d) 0.1 μM <i>cd9b</i> MO1, (e) 0.1 μM <i>cd9b</i> i2e3 MO1, (f) 0.2 μM <i>cd9b</i> MO1, (g) 0.2 μM <i>cd9b</i> i2e3 MO. …”
-
2026
MeHg Exposure Makes O-2A/OPCs More Oxidized, Suppresses BrdU Incorporation, and Decreases Cell Division in Clonal Assays
Published 2013“…In cultures exposed to MeHg, there was a decrease in the representation of large clones and a proportionate increase in the number of small clones and clones containing oligodendrocytes. …”
-
2027
-
2028
Combination metabolic therapy decreases VM-M3 cell viability <i>in vitro</i>.
Published 2015“…<b>(A-B)</b> βHB, LG, and LG+βHB+HBOT treatment decreased viability compared to control and HBOT treated cells. …”
-
2029
Combination metabolic therapy decreases VM-M3 cell proliferation <i>in vitro</i>.
Published 2015“…Cell density was measured with trypan blue hemocytometry to produce a growth curve over 96 hours. <b>(A)</b> Proliferation of VM-M3 cells was inhibited with decreasing glucose concentration and the addition of HBOT. …”
-
2030
-
2031
-
2032
-
2033
-
2034
A summary of the included study characteristics.
Published 2025“…There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”
-
2035
-
2036
Loss of Lsd1 in long bone mesenchymal cells disrupts growth plate organization but not collagen maturation.
Published 2022“…<p>(A) Growth plates of Lsd1 knockout mice have decreased organization and thicker hypertrophic zone (right) compared to control (left) (n = 4–5 per group). …”
-
2037
-
2038
-
2039
-
2040